[1]
“DEVELOPMENT OF STABILITY INDICATING RP-HPLC METHOD FOR MULTICOMPONENT TABLET FORMULATION CONTAINING ATAZANAVIR AND COBICISTAT”, Int. Res. J. Pharm., vol. 9, no. 5, pp. 85–89, May 2018, Accessed: Nov. 02, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/1070